In-Vitro_Diagnostics_Global Market Report_2018

h
In-Vitro Diagnostics
Global Market Report 2018
Including: Point-of-Care Diagnostics; Immunochemistry Diagnostics; Clinical Chemistry Diagnostics;
Molecular Diagnostics; Microbiology Diagnostics; Hemostasis Diagnostics; Hematology Diagnostics;
Immunohematology Diagnostics
Covering: Siemens Healthineers, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter Inc.), Abbott
Laboratories Inc., Thermo Fisher Scientific Inc.
Feb 2018

Reasons to Purchase
• Outperform competitors using accurate up to date demand-side dynamics
information.
• Identify growth segments for investment.
• Facilitate decision making on the basis of historic and forecast data and the
drivers and restraints on the market.
• Create regional and country strategies on the basis of local data and analysis.
• Stay abreast of the latest customer and market research findings
• Benchmark performance against key competitors.
• Develop strategies based on likely future developments.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high
quality data and analysis
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 3-5
working days of order.
Scope
Markets Covered: Point-of-Care Diagnostics; Immunochemistry; Clinical Chemistry;
Molecular Diagnostics; Microbiology; Hemostasis; Hematology; Immunohematology
Companies Mentioned: Siemens Healthineers, F. Hoffmann-La Roche Ltd, Danaher
(Beckman Coulter Inc.), Abbott Laboratories Inc., Thermo Fisher Scientific Inc.
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and
Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita,
The In-Vitro Diagnostics Market Indicators Comparison.
Data segmentations: Country and regional historic and forecast data, market share of
competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end
notes.

In-Vitro Diagnostics Market
Characteristics
In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and
also monitor a person’s state of health and therapeutic procedures by examining
specimens derived from the human body such as tissue, blood, stools, urine and
the other body fluids. Significant technologies incorporated in in-vitro diagnostics
are polymerase chain reaction, microarray techniques, sequencing technology and
mass spectrometry, which are used for test sample preparation. In-vitro diagnostic
medical devices include reagents, reagent products, control materials, calibration
materials, kits, instruments, apparatus, systems, equipment, pregnancy tests, urine
test strips, blood sugar monitoring systems for diabetics and receptacles for
medical specimens.
Based on techniques, in-vitro diagnostics are classified as follow:
Point-of-Care Diagnostics
These devices are designed to aid patients in
Immunochemistry Diagnostics
These devices are designed to diagnose diseases or
Clinical Chemistry Diagnostics
Clinical chemistry diagnostics are used to
Molecular Diagnostics
Molecular Diagnostics are used to

Hematology Diagnostic Instruments
Hematology diagnostic instruments are
Microbiology Diagnostic Devices
Microbiology diagnostic devices are used to
Hemostasis diagnostics
Hemostasis diagnostics are the devices used to
In this report market value is defined as the revenues organizations earn by selling
their goods and services within the specified market, based on the price at which
they sell. Only goods and services traded between entities are included.
The revenues for a specified geography are consumption values – that is, they are
revenues generated by organizations in the specified geography within the
specified market, irrespective of where they are produced.

In-Vitro Diagnostics Market
Historic Growth
The global in-vitro diagnostics market grew from $X billion in 2013 to $X billion in
2017 at a compound annual growth rate (CAGR) of X%.
The chart and table below shows the year-on-year growth of the global in-vitro
diagnostics market during 2013 – 2017.
Drivers of the Market:
Restraints on the Market

In-Vitro Diagnostics Market
Forecast Growth
The global in-vitro diagnostics market is expected to grow from $XX billion in 2017
to $68 billion in 2021 at a compound annual growth rate (CAGR) of XX%.
The chart and table below shows the year-on-year growth of the global in-vitro
diagnostics market during 2017 - 2021.
Drivers of the Market
Restraints on the Market

In-Vitro Diagnostics Market
Segmentation
The chart and table below shows the split of the in-vitro diagnostics market in
2017.
The total market value for in-vitro diagnostics was $X billion in 2017. The markets
that are covered include Point-of-Care Diagnostics; Immunochemistry Diagnostics;
Clinical Chemistry Diagnostics; Molecular Diagnostics; Microbiology Diagnostic
Devices; Hemostasis Diagnostics; Hematology Diagnostic Instruments;
Immunohematology Diagnostics Devices
Point-of-Care Diagnostics market was the x largest segment in the in-vitro
diagnostics market with X% share of the market. The market value for the point-ofcare
diagnostics market was $x billion in 2017.
Immunochemistry Diagnostics made up around X% share of the market. The
market value for the immunochemistry diagnostics was $x billion in 2017.

In-Vitro Diagnostics Market
Regional And Country Analysis
The Asia Pacific was the x largest region in the in-vitro diagnostics market in 2017,
in-vitro diagnostics for $X billion or X% market share.
North America was the x largest region in-vitro diagnostics for $X billion or X%
market share.
South America was the x largest region in-vitro diagnostics for $X billion or X%
market share.

In-Vitro Diagnostics Market
Competitive Landscape
The leading competitors in the global in-vitro diagnostics market are Siemens
Healthineers, F. Hoffmann-La Roche Ltd, Danaher (Beckman Coulter Inc.), Abbott
Laboratories Inc., Thermo Fisher Scientific Inc.
The chart and table below displays the percentage market share of the top players
in the in-vitro diagnostics market industry.
Siemens Healthineers generated revenues of $XX billion for the financial
year 2017, an XX% increase from the previous year.
F. Hoffmann-La Roche Ltd generated revenues of $XX billion for the
financial year 2016, an XX% increase from the previous year.
Danaher (Beckman Coulter Inc) generated revenues of $XX billion for the
financial year 2016, an XX% increase from the previous year.
Abbott Laboratories Inc. generated revenues of $XX billion for the financial
year 2016, an XX% increase from the previous year.

Thermo Fisher Scientific, Inc. generated revenues of $XX billion for the
financial year 2016, an XX% decrease from the previous year.
Sysmex Corporation generated revenues of $XX billion for the financial year
2016, an XX% increase from the previous year.
bioMérieux generated revenues of $XX billion for the financial year 2016,
an XX% increase from the previous year.
Becton Dickinson & Company generated revenues of $XX billion for the
financial year 2016, an XX% increase from the previous year.
Company Profile
Siemens Healthineers
Overview
Siemens Healthineers was the largest company in the in-vitro diagnostics
market in 2017 with a XX% share. It provides medical diagnostics
solutions, healthcare equipment and related services around the world.
Siemens Healthineers formerly known as Siemens Healthcare operates as a
subsidiary of Siemens AG and is headquartered in Erlangen, Germany.
Products and Services
Siemens Healthineers offers the following products and services
Medical Imaging products – It includes imaging and diagnostic products
Laboratory Diagnostics – It consists of immunoassay, hematology,
Healthcare IT & Infrastructure Solutions – It provides software and

Strategy
Siemens Healthineers’ growth strategy is to strengthen its portfolio across
the medical imaging and laboratory diagnostics business while adding new
offerings such as managed services, consulting and digital services in the
growing market for therapeutic and molecular diagnostics. In the first
quarter of 2016,
Financial Performance
Siemens Healthineers generated revenues of EUR XX billion ($XX billion)
for the financial year 2017, a XX% increase from the previous year.
Siemens AG had a market
F. Hoffmann-La Roche Ltd
Overview
Products and Services
Strategy
Financial Performance
Danaher (Beckman Coulter Inc.)
Overview
Products and Services
Strategy
Financial Performance
Abbott Laboratories Inc.
Overview
Products and Services
Strategy
Financial Performance

Thermo Fisher Scientific Inc.
Overview
Products and Services
Strategy
Financial Performance